FDA Inspection
Eisai, Inc.Eisai, Inc. – FDA Inspection, Sep 15, 2026
Record Details
This FDA Inspection record concerns Eisai, Inc., with an inspection on September 15, 2026, issued by the Baltimore District Office, covering human drugs.
View Company Profile
ID · 21cba403-4bda-47f1-b50e-b846dfd35feb
Inspection Facts
- Inspection number
- 1335274
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Eisai, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 9, 2024 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| July 22, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 17, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 9, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 12, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Eisai, Inc.
- FDA Inspection 1237510 - 2024-04-09
- FDA Inspection 977950 - 2016-07-22
- FDA Inspection 860646 - 2013-12-17
- FDA Inspection 722050 - 2011-05-09
- FDA Inspection 669338 - 2010-05-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.